Keiichi Isoyama
Showa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Cord blood index predicts engraftment and early non-relapse mortality in adult patients with single-unit cord blood transplantation.
Journal: Bone marrow transplantation
Published: February 08, 2021
Successful Treatment of Pediatric Refractory/Relapsed AML with KIR-Ligand-Mismatched Cord Blood Transplant after FLAG-IDA Reinduction Therapy with or without the GO Regimen.
Journal: Case reports in hematology
Published: September 19, 2019
Killer-cell immunoglobulin-like receptor ligand mismatch cord blood transplantation in high-risk neuroblastoma.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: October 04, 2018
Increased expression of interleukin-17 is associated with macrophages in chronic immune thrombocytopenia.
Journal: International journal of clinical and experimental pathology
Published: March 01, 2018
Initial presentation of lymphoblastic crisis in a pediatric chronic myelogenous leukemia patient
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: February 09, 2018
Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants.
Journal: Pediatric transplantation
Published: December 18, 2017
Wiskott-Aldrich syndrome that was initially diagnosed as immune thrombocytopenic purpura secondary to a cytomegalovirus infection.
Journal: SAGE open medical case reports
Published: November 14, 2017
Fludarabine, cytarabine, granulocyte colony-stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: May 26, 2017
Clinical features of, and association of bladder ultrasound and uroflowmetry with, overactive bladder recovery period in children.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: May 16, 2017
Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: April 04, 2017
Last Updated: 09/26/2026